Cyril Konto

Position in SVTR

Snapshot 2026-11-02

People SignalsRankedof 4,068↓12

🔒 Sign in for the exact rank and neighbours

Experience

Shennon BiotechnologiesChief Executive Officer
2026–
Ichnos Glenmark InnovationPresident & Chief Executive Officer
2022–2026
Ichnos SciencesChief Medical Officer
2021–2022
Allogene TherapeuticsVP, Clinical Development
2018–2021
Pfizer
2015–2018
Bristol-Myers Squibb
2011–2015

Full bio

Cyril Konto, CEO of Shennon Biotechnologies. President and CEO of Ichnos Glenmark Innovation from 2022 to 2026; Chief Medical Officer of Ichnos Sciences from 2021 to 2022.…

Latest moves

1 verified move in the last 90 days · Unlock with SVTR Intelligence

Funding of companies this person currently works at, from the SVTR AI Venture Database.

Relationship graph

Colleague / same employer· 1

Li Sun

Org / employer· 3

Shennon BiotechnologiesIchnos Glenmark InnovationIchnos Sciences

⬇

Co-founderColleague / same employerSchoolmateOrg / employerSchoolBigger circle = more prominent (media coverage) · ⛶ fullscreen · scroll / pinch to zoom · hover to highlight · drag nodes · click a node to open its profile